Transcripts

Dexcom (DXCM) earnings call transcripts

Earnings call transcripts for Dexcom, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Dexcom framed Q2 as broad-based execution supporting a larger reimbursement-led growth runway, with product adoption and operating leverage tracking ahead of plan. 9 million U.S.

    Jul 30, 2026Confident0.82